Sun Pharma is the largest pharma company of India with about 8.2 percent market share in the domestic formulation industry. It also gets a sizeable revenue from its global specialty business which fetches higher margin than the pharma generic business. Key watch for company in coming months is the progress for Specialty pipeline, the US tariffs on pharma products and expansion of domestic field force.
first published: Mar 12, 2025 08:05 am
A collection of the most-viewed Moneycontrol videos.
